10.1371/journal.pone.0185099.g007
Atefeh Razazan
Atefeh
Razazan
Javad Behravan
Javad
Behravan
Atefeh Arab
Atefeh
Arab
Nastaran Barati
Nastaran
Barati
Leila Arabi
Leila
Arabi
Zahra Gholizadeh
Zahra
Gholizadeh
Mahdi Hatamipour
Hatamipour
Amin Reza Nikpoor
Amin Reza
Nikpoor
Amir Abbas Momtazi-Borojeni
Amir Abbas
Momtazi-Borojeni
Fatemeh Mosaffa
Fatemeh
Mosaffa
Mohamad Hosein Ghahremani
Mohamad Hosein
Ghahremani
Mahmoud Reza Jaafari
Mahmoud
Reza Jaafari
Therapeutic effects of liposomal formulations in BALB/c mice against a TUBO tumor model.
Public Library of Science
2017
Lip-DOPE-MPL-GP 2 formulation
DMPG
DMPC
breast
IFN
mice xenograft model
TUBO mice model
GP 2 peptide
vaccine
fusogenic lipid dioleoylphosphatidylethanolamine
increase cytotoxic T lymphocyte
CTL
delivery system
Maleimide-mPEG 2000- DSPE micelles
HER
BALB
intracellular cytokine analysis
adjuvant
response
2017-10-18 17:38:37
Figure
https://plos.figshare.com/articles/figure/Therapeutic_effects_of_liposomal_formulations_in_BALB_c_mice_against_a_TUBO_tumor_model_/5511064
<p>Two weeks after inoculation of 5 ×10<sup>5</sup> TUBO cells to five mice in each group, different liposomal formulations were administrated three times with two-week intervals. After the first injection, the mice were challenged and tumor size was calculated based on three dimensions. (A) Tumor growth was measured two times every week. (B) The survival of mice was followed for 91 days. The data indicate the mean ±SEM(n = 5). ***<i>p</i><0.001 and ****<i>p</i><0.0001; denote significant difference from the HEPS-dextrose 5% group.</p>